tirzepatide from lilly Eli launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Lilly releases Zepbound® (tirzepatide) single-dose

Both Mounjaro and Zepbound are priced to reflect the value they can provide to individuals, health systems, and society in treating type 2 diabetes and obesity, Mr

It regulates appetite, reduces food cravings, and promotes sustained weight loss when used alongside a reduced-calorie diet and regular physical activity

And pursuing mRNA vaccines at full speed did not stop the government from also pursuing traditional vaccines and investigating other covid therapies, just as the field of addiction will continue to pursue improvement and expansion of use for existing medication classes

Sign up here to stay in the loop

- **Coding updates**: HCPCS and CPT codes are updated annually